Esteban Martínez Selected Research

Esteban Martínez Research Topics

Disease

19	Lipodystrophy 01/2015 - 12/2002
18	HIV Infections (HIV Infection) 01/2020 - 03/2002
9	Acquired Immunodeficiency Syndrome (AIDS) 03/2019 - 09/2003
7	Infections 01/2020 - 12/2002
6	Insulin Resistance 12/2021 - 10/2003
4	Fibrosis (Cirrhosis) 04/2022 - 01/2005
4	Inflammation (Inflammations) 12/2021 - 03/2008
4	Hyperlactatemia 12/2009 - 11/2003
3	COVID-19 01/2022 - 10/2020
3	Hepatitis B 01/2022 - 11/2004
3	Dyslipidemias (Dyslipidemia) 09/2014 - 02/2006
3	Coinfection 05/2014 - 01/2005
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2011 - 02/2006
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2010 - 10/2004
2	Heart Failure 12/2021 - 07/2002
2	Thrombophilia 12/2021 - 01/2010
2	Osteoporosis 10/2021 - 05/2018
2	Virus Diseases (Viral Diseases) 01/2015 - 01/2011
2	Chronic Renal Insufficiency 11/2014 - 01/2014
2	Necrosis 11/2014 - 09/2009
2	Pancreatitis 01/2013 - 07/2004
2	Hepatitis C 10/2012 - 11/2004
2	Diabetes Mellitus 01/2012 - 01/2010
2	Coronary Disease (Coronary Heart Disease) 01/2012 - 10/2004
2	Hypertension (High Blood Pressure) 01/2012 - 01/2010
2	Encephalitis (Encephalitis, Rasmussen) 03/2011 - 07/2006
2	Lactic Acidosis 01/2005 - 03/2002
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2022
1	Weight Gain 12/2021
1	Opportunistic Infections (Opportunistic Infection) 04/2016
1	Human Influenza (Influenza) 02/2015
1	Lipomatosis 01/2015
1	Obesity 01/2015
1	Glycosuria 11/2014
1	Atrophy 08/2014
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2013
1	Atherosclerosis 11/2012
1	Liver Diseases (Liver Disease) 03/2011

Drug/Important Bio-Agent (IBA)

8	Mitochondrial DNA (mtDNA)IBA 01/2019 - 08/2003
6	LipidsIBA 01/2022 - 09/2003
6	Triglycerides (Triacylglycerol)IBA 01/2022 - 10/2003
6	Protease Inhibitors (Protease Inhibitor)IBA 09/2014 - 09/2003
6	Pharmaceutical PreparationsIBA 12/2012 - 03/2002
5	CholesterolIBA 01/2022 - 04/2004
5	Tenofovir (Viread)FDA Link 10/2020 - 07/2004
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2010
4	RNA (Ribonucleic Acid)IBA 10/2021 - 09/2003
3	Antiviral Agents (Antivirals)IBA 04/2022 - 01/2011
3	LDL CholesterolIBA 01/2022 - 01/2010
3	HDL CholesterolIBA 01/2022 - 01/2010
3	abacavir (Ziagen)FDA Link 10/2020 - 09/2003
3	Reverse Transcriptase InhibitorsIBA 10/2020 - 03/2002
3	NucleosidesIBA 01/2011 - 03/2002
2	HDL LipoproteinsIBA 01/2022 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 01/2019
2	AdiponectinIBA 12/2021 - 01/2010
2	Emtricitabine (Emtriva)FDA Link 10/2020 - 01/2010
2	Lamivudine (Epivir)FDA Link 10/2020 - 01/2011
2	Rilpivirine (TMC-278)IBA 01/2020 - 06/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 01/2010
2	Interleukin-6 (Interleukin 6)IBA 11/2014 - 09/2009
2	InterleukinsIBA 05/2014 - 01/2010
2	Stavudine (Zerit)FDA LinkGeneric 01/2013 - 01/2005
2	ThymidineIBA 01/2011 - 07/2009
2	C-Reactive ProteinIBA 01/2010 - 09/2009
2	efavirenz (Sustiva)FDA Link 08/2008 - 09/2003
1	Biological ProductsIBA 04/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2022
1	Lipopolysaccharide ReceptorsIBA 12/2021
1	RacivirIBA 10/2020
1	tenofovir alafenamideIBA 10/2020
1	pyrimidineIBA 01/2020
1	Darunavir (Prezista)FDA Link 01/2020
1	dolutegravirIBA 03/2015
1	Nucleic AcidsIBA 02/2015
1	SmokeIBA 01/2015
1	CytokinesIBA 01/2015
1	Phosphates (Orthophosphate)IBA 11/2014
1	Ezetimibe (Zetia)FDA Link 09/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2014
1	Ritonavir (Norvir)FDA Link 05/2014
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 05/2014
1	oxidized low density lipoproteinIBA 02/2013
1	Thymidylate SynthaseIBA 01/2013
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2013
1	stavudine triphosphateIBA 01/2013
1	Interferon-alpha (Interferon Alfa)IBA 10/2012
1	Ribavirin (Virazole)FDA LinkGeneric 10/2012
1	Lipoprotein(a)IBA 01/2012
1	Genetic Markers (Genetic Marker)IBA 01/2012
1	fibrin fragment D (D-dimer)IBA 01/2010
1	Interleukin-10 (Interleukin 10)IBA 01/2010
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2010
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2010

Therapy/Procedure

26	Therapeutics 04/2022 - 03/2002
19	Highly Active Antiretroviral Therapy (HAART) 01/2015 - 07/2002
4	Art Therapy 10/2020 - 02/2013
2	Aftercare (After-Treatment) 08/2014 - 01/2005
1	Palliative Care (Palliative Therapy) 04/2016